Welcome to IGP
The department conducts advanced research and education in areas such as clinical immunology, medical genetics and genomics, pathology, oncology, vascular biology, molecular tools and medical radiation sciences.
Some of our activities are integrated with clinics at Uppsala University Hospital:
Clinical genetics
Clinical pathology
Clinical immunology and transfusion medicine
Oncology
Hospital physics
New research findings from IGP |
|
New biomarker test improves diagnosis of ovarian cancer The majority of women who undergo surgery for suspected ovarian cancer do not have cancer. A novel blood test developed by Ulf Gyllensten’s research group, together with colleagues at Uppsala University and the Sahlgrenska Academy, at University of Gothenburg, now offers the possibility of more precise diagnostics without the need for surgery. This could lead to a reduction in unnecessary surgery and to earlier detection and treatment for affected women. |
|
Inhibition of ribosome biogenesis as a novel approach for multi-stage cancer treatment Nearly ninety per cent of all cancer patient deaths are due to metastasis. A study from IGP shows that a process that allows the cells to metastasise is aided by the synthesis of new ribosomes, the cell components in which proteins are produced. The results open the possibility for new treatment strategies for advanced cancers. The study is published in Nature Communications. |
|
Our genes affect where fat is stored in our bodies A recent study from IGP has found that whether you store your fat around the trunk or in other parts of your body is highly influenced by genetic factors and that this effect is present predominantly in women and to a much lower extent in men. In the study, which is published in Nature Communications, the researchers measured how fat was distributed in nearly 360,000 voluntary participants. |
